XML 82 R71.htm IDEA: XBRL DOCUMENT v3.24.3
Segments and Disaggregated Revenue (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Segments and Disaggregated Revenue          
Revenue $ 1,753,223 $ 3,965,361 $ 3,932,592 $ 14,566,351  
Cost of revenue 1,878,799 4,501,393 3,618,031 15,138,225  
Operating expenses 2,115,509 1,855,101 5,336,488 9,472,809  
Operating loss (2,241,085) (2,391,133) (5,021,927) (10,044,683)  
Other income (expense) (1,475,020) (293,458) (8,119,147) (22,450)  
Loss before income taxes (3,716,105) (2,684,591) (13,141,074) (10,067,133)  
Common stock deemed dividend     (475,713)    
Income (loss) from discontinued operations (923,543) 2,776,013 (2,615,965)  
Net loss attributable to common stockholders (3,716,105) (3,608,134) (11,511,655) (12,683,098)  
Total assets 9,799,261   9,799,261   $ 17,211,275
Operating Segments [Member]          
Segments and Disaggregated Revenue          
Revenue 1,753,223 3,965,361 3,932,592 14,566,351  
Cost of revenue 1,878,799 4,501,393 3,618,031 15,138,225  
Operating expenses 2,115,509 1,855,101 5,336,488 9,472,809  
Operating loss (2,241,085) (2,391,133) (5,021,927) (10,044,683)  
Other income (expense) (1,475,020) (293,458) (8,119,147) (22,450)  
Loss before income taxes (3,716,105) (2,684,591) (13,141,074) (10,067,133)  
Common stock deemed dividend   (1,146,594)    
Net income attributable to non-controlling interest    
Income (loss) from discontinued operations   (923,543) 2,776,013 (2,615,965)  
Net loss attributable to common stockholders (3,716,105) (3,608,134) (11,511,655) (12,683,098)  
Total assets 9,799,262 13,681,609 9,799,262 13,681,609  
Depreciation and amortization 115,086 485,854 200,120 1,538,660  
Capital expenditures 1,136 526,252 8,007 530,055  
Operating Segments [Member] | Construction [Member]          
Segments and Disaggregated Revenue          
Revenue 1,753,223 3,965,361 3,932,592 14,566,351  
Cost of revenue 1,878,799 4,501,393 3,618,031 15,138,225  
Operating expenses 21,842 (108,603) 113,656 68,384  
Operating loss (147,418) (427,429) 200,905 (640,258)  
Other income (expense) (87,413) (308,988) (275,321) (56,796)  
Loss before income taxes (234,831) (736,417) (74,416) (697,054)  
Common stock deemed dividend      
Net income attributable to non-controlling interest    
Income (loss) from discontinued operations    
Net loss attributable to common stockholders (234,831) (736,417) (74,416) (697,054)  
Total assets 5,778,540 7,111,643 5,778,540 7,111,643  
Depreciation and amortization 113,256 53,147 194,803 146,917  
Capital expenditures 1,136 8,007  
Operating Segments [Member] | Medical [Member]          
Segments and Disaggregated Revenue          
Revenue  
Cost of revenue  
Operating expenses 10,012 138,240 95,972 139,135  
Operating loss (10,012) (138,240) (95,972) (139,135)  
Other income (expense)  
Loss before income taxes (10,012) (138,240) (95,972) (139,135)  
Common stock deemed dividend      
Net income attributable to non-controlling interest    
Income (loss) from discontinued operations    
Net loss attributable to common stockholders (10,012) (138,240) (95,972) (139,135)  
Total assets 1,406 4,581 1,406 4,581  
Depreciation and amortization  
Capital expenditures  
Operating Segments [Member] | Corporate and support [Member]          
Segments and Disaggregated Revenue          
Revenue  
Cost of revenue  
Operating expenses 2,083,655 1,825,464 5,126,860 9,265,290  
Operating loss (2,083,655) (1,825,464) (5,126,860) (9,265,290)  
Other income (expense) (1,387,607) 15,530 (7,843,826) 34,346  
Loss before income taxes (3,471,262) (1,809,934) (12,970,686) (9,230,944)  
Common stock deemed dividend   (1,146,594)    
Net income attributable to non-controlling interest    
Income (loss) from discontinued operations   (923,543) 2,776,013 (2,615,965)  
Net loss attributable to common stockholders (3,471,262) (2,733,477) (11,341,267) (11,846,909)  
Total assets 4,019,316 6,565,385 4,019,316 6,565,385  
Depreciation and amortization 1,830 432,707 5,317 1,391,743  
Capital expenditures $ 526,252 $ 530,055